Antibodies targeting Prostate-Specific Membrane Antigen positive prostate cancer: from diagnostic imaging to theranostics.,Current Opinion in Oncology

当前位置： X-MOL 学术 › Curr. Opin. Oncol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Antibodies targeting Prostate-Specific Membrane Antigen positive prostate cancer: from diagnostic imaging to theranostics.
Current Opinion in Oncology ( IF 3.4 ) Pub Date : 2021-07-06 , DOI: 10.1097/cco.0000000000000767
Thierry Roumeguère _{1,

2} , Fouad Aoun _{1,

2} , Simone Albisinni _{1,

2} , Georges Mjaess ₁

Affiliation

Targeting Prostate-Specific Membrane Antigen (PSMA) has paved the way for personalized medicine in prostate cancer (PCa) patients. This review aims to highlight the role of PSMA targeting antibodies in PCa, for diagnostic and therapeutic purposes.

中文翻译：